Hour One partners with NextLeap Cosmetics
Dallas, TX
Introducing NextLeap - a revolutionary new cosmetic product designed to address cold sores using the ground-breaking Tranexamic Acid that addresses skin discoloration.
Tranexamic Acid is widely used in cosmetics to reduce the appearance of skin discoloration, primarily caused by aging and sunlight damage. NextLeap can be effectively used for that purpose, ideally underneath a hydration, dark spot or exfoliation product. The formula has been optimized to address the skin discoloration caused by cold sores as well using the highest quality ingredients.
“NextLeap has been extensively tested with the leading therapies, such as Abreva™ (or generic Docosanol 10%) and acyclovir, to ensure that NextLeap provides its cosmetic benefit against skin discoloration compatibly with the healing effect of the cold sore therapy,” says Paul Stewart, Co-Founder.
“If cold sore treatments have not worked for you as well as you hoped, applying NextLeap underneath a topical cold sore therapy should provide you with a much faster return to normal appearance and let you get back to your life.”
Co-Founder, Frank Murdock explains, “Our mission is to give peace of mind for the one in four people who are affected by cold sores so they can get back to looking like themselves sooner.”
Visit NextLeapCosmetics.com
(“Abreva” is a trademark of the GSK group of companies.)
---